The Epidemiology and Risk Assessment of Mucositis
作者： Stephen T. Sonis
DOI: 10.1007/978-1-907673-46-7_3
关键词: Oncology 、 Internal medicine 、 Larynx 、 Medicine 、 Mucositis 、 Radiation therapy 、 Risk assessment 、 Epidemiology 、 Cancer therapy 、 Total body irradiation 、 Treatment field
摘要: OM is among the most common and dreaded toxicities of cancer therapy [1]. It occurs in almost all patients who receive radiation which areas oral or oropharyngeal mucosa are included treatment field. Thus for with cancers mouth, oropharynx, hypopharynx, larynx, nasopharynx, salivary glands, clinically significant about 70 % [2].
springer.com
sci-hub.st 参考文章(30)
Stephen T. Sonis, Douglas E. Peterson, E. George Elias, Head and Neck Management of the Cancer Patient ,(2011)
Douglas E. Peterson, Oral Complications Associated with Hematologic Neoplasms and their Treatment Head and Neck Management of the Cancer Patient. pp. 351- 361 ,(1986) , 10.1007/978-1-4613-2289-4_19
Stephen T Sonis, A biological approach to mucositis. The journal of supportive oncology. ,vol. 2, pp. 21- 36 ,(2004)
Stephen T Sonis, Oral mucositis in cancer therapy. The journal of supportive oncology. ,vol. 2, pp. 3- 8 ,(2004)
Christine B Ambrosone, Chunqiao Tian, Jiyoung Ahn, Silke Kropp, Irmgard Helmbold, Dietrich von Fournier, Wulf Haase, Marie Luise Sautter-Bihl, Frederik Wenz, Jenny Chang-Claude, Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study Breast Cancer Research. ,vol. 8, pp. 1- 7 ,(2006) , 10.1186/BCR1526
Charlotte C. Sun, Diane C. Bodurka, Candice B. Weaver, Rafia Rasu, Judith K. Wolf, Michael W. Bevers, Judith A. Smith, J. Taylor Wharton, Edward B. Rubenstein, Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer Supportive Care in Cancer. ,vol. 13, pp. 219- 227 ,(2005) , 10.1007/S00520-004-0710-6
Sook-Bin Woo, Stephen T. Sonis, Andrew L. Sonis, The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients Cancer. ,vol. 66, pp. 2375- 2379 ,(1990) , 10.1002/1097-0142(19901201)66:11<2375::AID-CNCR2820661121>3.0.CO;2-6
Nicole Blijlevens, Matthias Schwenkglenks, Pamela Bacon, Alessandra D'Addio, Hermann Einsele, Johan Maertens, Dietger Niederwieser, Werner Rabitsch, Ann Roosaar, Tapani Ruutu, Harry Schouten, Rebecca Stone, Samuel Vokurka, Barry Quinn, Shaun McCann, Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group Journal of Clinical Oncology. ,vol. 26, pp. 1519- 1525 ,(2008) , 10.1200/JCO.2007.13.6028
M. IGAWA, H. KADENA, M. UEDA, T. USUI, Association between patient characteristics and treatment history, and toxicity associated with methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) for advanced urothelial cancer BJUI. ,vol. 73, pp. 263- 267 ,(1994) , 10.1111/J.1464-410X.1994.TB07515.X
P B Lockhart, M T Brennan, M L Kent, C H Packman, H J Norton, P C Fox, G Frenette, Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation. Bone Marrow Transplantation. ,vol. 35, pp. 713- 720 ,(2005) , 10.1038/SJ.BMT.1704820